Publicaciones (43) Publicaciones de AMALIA LAMANA DOMÍNGUEZ

2024

  1. Vasoactive intestinal peptide exerts an osteoinductive effect in human mesenchymal stem cells

    BioFactors

2023

  1. Occurrence of SARS-CoV-2 viremia is associated with genetic variants of genes related to COVID-19 pathogenesis

    Frontiers in Medicine, Vol. 10

2022

  1. Galectin-1: A Potential Biomarker Differentiating between Early Rheumatoid Arthritis and Spondyloarthritis

    Journal of Clinical Medicine, Vol. 11, Núm. 21

  2. Genetic LGALS1 Variants Are Associated with Heterogeneity in Galectin‐1 Serum Levels in Patients with Early Arthritis

    International Journal of Molecular Sciences, Vol. 23, Núm. 13

  3. Human CD4+CD45RA+ T Cells Behavior after In Vitro Activation: Modulatory Role of Vasoactive Intestinal Peptide

    International Journal of Molecular Sciences, Vol. 23, Núm. 4

  4. VIP/VPAC Axis Expression in Immune-Mediated Inflammatory Disorders: Associated miRNA Signatures

    International journal of molecular sciences, Vol. 23, Núm. 15

2021

  1. The neuropeptide vip limits human osteoclastogenesis: Clinical associations with bone metabolism markers in patients with early arthritis

    Biomedicines, Vol. 9, Núm. 12

2020

  1. A clinical approach for the use of VIP axis in inflammatory and autoimmune diseases

    International Journal of Molecular Sciences, Vol. 21, Núm. 1

  2. Comparative Study of Senescent Th Biomarkers in Healthy Donors and Early Arthritis Patients. Analysis of VPAC Receptors and Their Influence

    Cells, Vol. 9, Núm. 12

  3. Identification of a Human SOCS1 Polymorphism That Predicts Rheumatoid Arthritis Severity

    Frontiers in Immunology, Vol. 11

  4. Utility of circulating serum miRNA profiles to evaluate the potential risk and severity of immune-mediated inflammatory disorders

    Journal of Autoimmunity, Vol. 111

  5. Validation of galectin-1 as potential diagnostic biomarker of early rheumatoid arthritis

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. An Overview of VPAC Receptors in Rheumatoid Arthritis: Biological Role and Clinical Significance

    Frontiers in Endocrinology, Vol. 10

2018

  1. Amiloidosis derivada del factor quimiotáctico de leucocitos 2 (ALECT2): a propósito de un caso

    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, Vol. 38, Núm. 5, pp. 558-560

  2. LECT2-associated renal amyloidosis (ALECT2): A case report

    Nefrologia

  3. Methotrexate limits inflammation through an A20-dependent cross-tolerance mechanism

    Annals of the Rheumatic Diseases, Vol. 77, Núm. 5, pp. 752-759

  4. Vasoactive intestinal peptide gene polymorphisms, associated with its serum levels, predict treatment requirements in early rheumatoid arthritis

    Scientific Reports, Vol. 8, Núm. 1

2017

  1. Impact of genetic variants of ATP binding cassette B1, AICAR transformylase/IMP cyclohydrolase, folyl-polyglutamatesynthetase, and methylenetetrahydrofolatereductase on methotrexate toxicity

    Reumatologia Clinica, Vol. 13, Núm. 6, pp. 318-325

  2. mRNA profilin identifies low levels of phosphatases dual-specific phosphatase-7 (DUSP7) and cell division cycle-25B (CDC25B) in patients with early arthritis

    Clinical and Experimental Immunology, Vol. 189, Núm. 1, pp. 113-119

2016

  1. Clinical relevance of VPAC1 receptor expression in early arthritis: Association with IL-6 and disease activity

    PLoS ONE, Vol. 11, Núm. 2